Understanding how the immune system responds to life-threatening bloodstream infections could transform early detection strategies for one of medicine's most challenging emergencies. Sepsis kills more than 250,000 Americans annually, often because the body's inflammatory response spirals beyond control before clinicians can intervene effectively. A sophisticated new mouse model now provides unprecedented real-time visibility into this deadly cascade, potentially opening pathways to better therapeutic timing. Researchers used the fecal suspension test to induce polymicrobial sepsis in laboratory mice, then deployed advanced flow cytometry and plasma analysis to track immune cell populations minute-by-minute during the acute phase. The data reveals sepsis follows a predictable two-stage pattern: an initial pro-inflammatory surge followed by a compensatory anti-inflammatory phase. Central to this transition are myeloid-derived suppressor cells, specialized immune cells that appear to orchestrate the shift from inflammation to immune suppression. The study also identified emergency myelopoiesis—rapid production of new immune cells from bone marrow—as a critical component of the body's sepsis response. This granular mapping of sepsis progression represents a significant methodological advance over previous research, which typically relied on single time-point snapshots. The ability to simultaneously track immune cell dynamics, inflammatory markers, and microbial populations in real-time could accelerate development of precision therapies timed to specific phases of septic shock, potentially improving survival rates in this devastating condition.